Johnson Fistel Notifies Investors of Class Action against DBV Technologies S.A. (DBVT) & Lead Plaintiff Deadline
SAN DIEGO, Jan. 23, 2019 /PRNewswire/ -- Shareholder Rights Law Firm Johnson Fistel, LLP announces that a class action lawsuit has commenced on behalf of persons or entities who purchased or otherwise acquired securities of DBV Technologies S.A. (NYSE: DBVT) ("DBV Technologies") from February 14, 2018 through December 19, 2018, inclusive (the "Class Period"). The lawsuit seeks to recover damages for investors under the federal securities laws.
According to the lawsuit, defendants made false and misleading statements and failed to disclose that: (1) DBV Technologies' Biologics License Application ("BLA") for Viaskin Peanut failed to provide the FDA with sufficient data on manufacturing procedures and quality controls; (2) consequently, DBV Technologies voluntarily withdrew the BLA for Viaskin Peanut; and (3) as a result, defendants' statements about DBV Technologies' business, operations, and prospects were materially false and/or misleading and lacked a reasonable basis at all relevant times.
Shareholders have until March 18, 2019, to seek appointment as a lead plaintiff. There is no cost or obligation to you. Your ability to share in any future recovery is not dependent upon serving as a lead plaintiff.
If you are interested in learning more about your legal rights and remedies, please contact Jim Baker ([email protected]) at 619-814-4471. If you email, please include your phone number.
Additionally, you can [Click here to join this action]. There is no cost or obligation to you.
About Johnson Fistel, LLP:
Johnson Fistel, LLP is a nationally recognized shareholder rights law firm with offices in California, New York, and Georgia. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits. For more information about the firm and its attorneys, please visit https://www.johnsonfistel.com. Attorney advertising. Past results do not guarantee future outcomes.
Contact:
Johnson Fistel, LLP
Jim Baker, 619-814-4471
[email protected]
[Click here to join this action]
SOURCE Johnson Fistel, LLP
Share this article